Rondi A. Butler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rondi A. Butler has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Brock C. Christensen
Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, USA
4 shared publications - Karl T. Kelsey
Department of Epidemiology, School of Public Health, Brown University , Providence, RI
4 shared publications - Devin C. Koestler
Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, USA
3 shared publications - John K. Wiencke
Department of Neurological Surgery, University of California San Francisco, San Francisco, USA
3 shared publications - Lucas Andrés Salas
Department of Cancer Biology, Guarini School of Graduate and Advanced Studies, Dartmouth College, Hanover, NH, USA
3 shared publications - Ze Zhang
Dana-Farber Cancer Institute
3 shared publications
Latest Publications
- Open Access
- 17 May 2024
- Published by Taylor & Francis in Epigenomics
- Vol. 16 (11-12) , 799-807
Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors
Aim: This study addresses the challenge of predicting the response of head and neck squamous cell carcinoma (HNSCC) patients to immunotherapy.Methods: Using DNA methylation cytometry, we analyzed the immune profiles of six HNSCC patients who showed a positive response to immunotherapy over a year without disease progression.Results: There was an initial increase in CD8 T memory cells and natural killer cells during the first four cycles of immunotherapy, which then returned to baseline levels after a year. Baseline CD8 T cell levels were lower in HNSCC immunotherapy responders but became similar to those in healthy subjects after immunotherapy.Conclusion: These findings suggest that monitoring fluctuations in immune profiles could potentially identify biomarkers for immunotherapy response in HNSCC patients.
- 17 May 2024
- Published by Taylor & Francis in Epigenomics
- Vol. 16 (11-12) , 799-807
Open AccessImmunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors
Aim: This study addresses the challenge of predicting the response of head and neck squamous cell carcinoma (HNSCC) patients to immunotherapy.Methods: Using DNA methylation cytometry, we analyzed the immune profiles of six HNSCC patients who showed a positive response to immunotherapy over a year without disease progression.Results: There was an initial increase in CD8 T memory cells and natural killer cells during the first four cycles of immunotherapy, which then returned to baseline levels after a year. Baseline CD8 T cell levels were lower in HNSCC immunotherapy responders but became similar to those in healthy subjects after immunotherapy.Conclusion: These findings suggest that monitoring fluctuations in immune profiles could potentially identify biomarkers for immunotherapy response in HNSCC patients.
- Open Access
- 15 December 2022
- Published by Springer Nature in Clinical Epigenetics
- Vol. 14 (1) , 1-14
Comparative analysis of the DNA methylation landscape in CD4, CD8, and B memory lineages
Background: There is considerable evidence that epigenetic mechanisms and DNA methylation are critical drivers of immune cell lineage differentiation and activation. However, there has been limited coordinated investigation of common epigenetic pathways among cell lineages. Further, it remains unclear if long-lived memory cell subtypes differentiate distinctly by cell lineages. Results: We used the Illumina EPIC array to investigate the consistency of DNA methylation in B cell, CD4 T, and CD8 T naïve and memory cells states. In the process of naïve to memory activation across the three lineages, we identify considerable shared epigenetic regulation at the DNA level for immune memory generation. Further, in central to effector memory differentiation, our analyses revealed specific CpG dinucleotides and genes in CD4 T and CD8 T cells with DNA methylation changes. Finally, we identified unique DNA methylation patterns in terminally differentiated effector memory (TEMRA) CD8 T cells compared to other CD8 T memory cell subtypes. Conclusions: Our data suggest that epigenetic alterations are widespread and essential in generating human lymphocyte memory. Unique profiles are involved in methylation changes that accompany memory genesis in the three subtypes of lymphocytes.
- 15 December 2022
- Published by Springer Nature in Clinical Epigenetics
- Vol. 14 (1) , 1-14
Open AccessComparative analysis of the DNA methylation landscape in CD4, CD8, and B memory lineages
Background: There is considerable evidence that epigenetic mechanisms and DNA methylation are critical drivers of immune cell lineage differentiation and activation. However, there has been limited coordinated investigation of common epigenetic pathways among cell lineages. Further, it remains unclear if long-lived memory cell subtypes differentiate distinctly by cell lineages. Results: We used the Illumina EPIC array to investigate the consistency of DNA methylation in B cell, CD4 T, and CD8 T naïve and memory cells states. In the process of naïve to memory activation across the three lineages, we identify considerable shared epigenetic regulation at the DNA level for immune memory generation. Further, in central to effector memory differentiation, our analyses revealed specific CpG dinucleotides and genes in CD4 T and CD8 T cells with DNA methylation changes. Finally, we identified unique DNA methylation patterns in terminally differentiated effector memory (TEMRA) CD8 T cells compared to other CD8 T memory cell subtypes. Conclusions: Our data suggest that epigenetic alterations are widespread and essential in generating human lymphocyte memory. Unique profiles are involved in methylation changes that accompany memory genesis in the three subtypes of lymphocytes.
- Top Cited PapersOpen Access
- 9 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling
DNA methylation microarrays can be employed to interrogate cell-type composition in complex tissues. Here, we expand reference-based deconvolution of blood DNA methylation to include 12 leukocyte subtypes (neutrophils, eosinophils, basophils, monocytes, naïve and memory B cells, naïve and memory CD4 + and CD8 + T cells, natural killer, and T regulatory cells). Including derived variables, our method provides 56 immune profile variables. The IDOL (IDentifying Optimal Libraries) algorithm was used to identify libraries for deconvolution of DNA methylation data for current and previous platforms. The accuracy of deconvolution estimates obtained using our enhanced libraries was validated using artificial mixtures and whole-blood DNA methylation with known cellular composition from flow cytometry. We applied our libraries to deconvolve cancer, aging, and autoimmune disease datasets. In conclusion, these libraries enable a detailed representation of immune-cell profiles in blood using only DNA and facilitate a standardized, thorough investigation of immune profiles in human health and disease.
- 9 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-13
Top Cited PapersOpen AccessEnhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling
DNA methylation microarrays can be employed to interrogate cell-type composition in complex tissues. Here, we expand reference-based deconvolution of blood DNA methylation to include 12 leukocyte subtypes (neutrophils, eosinophils, basophils, monocytes, naïve and memory B cells, naïve and memory CD4 + and CD8 + T cells, natural killer, and T regulatory cells). Including derived variables, our method provides 56 immune profile variables. The IDOL (IDentifying Optimal Libraries) algorithm was used to identify libraries for deconvolution of DNA methylation data for current and previous platforms. The accuracy of deconvolution estimates obtained using our enhanced libraries was validated using artificial mixtures and whole-blood DNA methylation with known cellular composition from flow cytometry. We applied our libraries to deconvolve cancer, aging, and autoimmune disease datasets. In conclusion, these libraries enable a detailed representation of immune-cell profiles in blood using only DNA and facilitate a standardized, thorough investigation of immune profiles in human health and disease.
- Open Access
- 1 March 2012
- Published by Taylor & Francis in Epigenetics
- Vol. 7 (3) , 291-299
Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: An epigenome-wide association study
Head and neck cancer accounts for an estimated 47,560 new cases and 11,480 deaths annually in the United States, the majority of which are squamous cell carcinomas (HNSCC). The overall 5 year survi...
- 1 March 2012
- Published by Taylor & Francis in Epigenetics
- Vol. 7 (3) , 291-299
Open AccessPeripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: An epigenome-wide association study
Head and neck cancer accounts for an estimated 47,560 new cases and 11,480 deaths annually in the United States, the majority of which are squamous cell carcinomas (HNSCC). The overall 5 year survi...